Article
Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic options
1 Aug 2017
Abstract excerpt
The onset of global epigenetic changes in chromatin that drive tumor proliferation and heterogeneity is a hallmark of many forms of cancer. Identifying the epigenetic mechanisms that govern these changes and developing therapeutic approaches to modulate them, is a well-established avenue pursued in translational cancer medicine. Chronic myeloid leukemia (CML) arises clonally when a hematopoietic stem cell (HSC)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
